You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 2, February 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Invited Commentary

Kazutomo Inoue, MD

Arch Surg. 1996;131(2):175.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is widely accepted that survival following gastrectomy for gastric cancer is superior for Japanese patients. Surgeons in Japan have demonstrated that curative resection with extensive lymphadenectomy leads to the high survival rate for gastric cancer, whereas some surgeons in the United States question if superior Japanese outcomes might be explained, in part, by racial factors. Hundahl and colleagues retrospectively compared the stage-stratified survival of gastrectomized Japanese patients in Honolulu treated for gastric cancer according to Western techniques with that of a cohort of Tokyo Japanese patients treated according to Japanese techniques, thus eliminating race as a potentially confounding variable. The authors proposed three hypotheses (the different-disease hypothesis, stage-migration hypothesis, and treatment hypothesis) explaining the better Japanese survival rates and concluded that these results cannot be explained by race-related factors or the different-disease hypothesis, but seem more likely to be explained by the lymphadenectomy-related stage migration and/or therapeutic efficacy.

In . . . [Full Text PDF of this Article]


Author Affiliations

Kyoto, Japan



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.